Insys Therapeutics has agreed to pay $225 million to resolve civil and criminal actions brought by the U.S. Department of Justice over alleged kickbacks and marketing of its opioid painkiller.
4 minute read
The agreement, announced Wednesday, resolves civil and criminal allegations that Insys bribed medical professionals to use its opioid painkiller.
June 05, 2019 at 08:03 PM
1 minute read
staff reporter
The original version of this story was published on Law.com
Insys Therapeutics has agreed to pay $225 million to resolve civil and criminal actions brought by the U.S. Department of Justice over alleged kickbacks and marketing of its opioid painkiller.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
